Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Immunovant, Inc. | 120,773 | reported | 01 Dec 2025 | tx 19+410,389−20,425 |
| Eargo, Inc. | 0 | reported | 23 Nov 2022 | tx 7+257,451−42,259 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Dec 2025 | SALE | Immunovant, Inc. | 13,091 | 23.14 USD | |
| 01 Dec 2025 | SALE | Immunovant, Inc. | 1,909 | 23.96 USD | |
| 01 Apr 2025 | GRANT_AWARD | Immunovant, Inc. | 16,188 | 0.00 USD | |
| 01 Apr 2025 | GRANT_AWARD | Immunovant, Inc. | 7,600 | 0.00 USD | deriv |
| 02 Dec 2024 | SALE | Immunovant, Inc. | 5,425 | 28.54 USD | |
| 02 Apr 2024 | GRANT_AWARD | Immunovant, Inc. | 11,255 | 0.00 USD | |
| 02 Apr 2024 | GRANT_AWARD | Immunovant, Inc. | 4,690 | 0.00 USD | deriv |
| 12 Apr 2023 | GRANT_AWARD | Immunovant, Inc. | 12,523 | 0.00 USD | |
| 12 Apr 2023 | GRANT_AWARD | Immunovant, Inc. | 16,260 | 0.00 USD | deriv |
| 22 Nov 2022 | EXERCISE | Eargo, Inc. | 71,363 | 0.50 USD | |
| 23 Nov 2022 | EXERCISE | Eargo, Inc. | 7,500 | 0.00 USD | deriv |
| 12 Oct 2022 | GRANT_AWARD | Eargo, Inc. | 74,074 | 0.00 USD | deriv |
| 23 Aug 2022 | GRANT_AWARD | Eargo, Inc. | 74,805 | 0.00 USD | deriv |
| 17 Aug 2022 | GRANT_AWARD | Immunovant, Inc. | 21,059 | 0.00 USD | |
| 17 Aug 2022 | GRANT_AWARD | Immunovant, Inc. | 31,668 | 0.00 USD | deriv |
| 10 Jan 2022 | GRANT_AWARD | Immunovant, Inc. | 21,726 | 0.00 USD | |
| 10 Jan 2022 | GRANT_AWARD | Immunovant, Inc. | 71,492 | 0.00 USD | deriv |
| 27 Aug 2021 | PURCHASE | Immunovant, Inc. | 18,247 | 8.24 USD | |
| 27 Apr 2021 | SALE | Eargo, Inc. | 1,500 | 55.00 USD | |
| 19 Mar 2021 | GRANT_AWARD | Immunovant, Inc. | 15,500 | 0.00 USD | |
| 19 Mar 2021 | GRANT_AWARD | Immunovant, Inc. | 23,300 | 0.00 USD | deriv |
| 20 Oct 2020 | CONVERSION | Eargo, Inc. | 37,209 | — | |
| 20 Oct 2020 | CONVERSION | Eargo, Inc. | 33,259 | 0.00 USD | deriv |
| 15 May 2020 | GRANT_AWARD | Immunovant, Inc. | 24,700 | 0.00 USD | |
| 15 May 2020 | GRANT_AWARD | Immunovant, Inc. | 37,000 | 0.00 USD | deriv |